Our previous studies using an animal model of OVX-induced osteoporotic pain suggest that treatment of osteoporosis is useful for osteoporotic pain associated with osteoclast activity and TRPV1 stimulation [13,14]. This evidence concerns the gene TRPV1 and osteoporosis.